Trial
NCT04159701
A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Chronic Spontaneous Urticaria
Intervention
LY3454738
Why stopped
The study was terminated for lack of efficacy after an interim analysis was performed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-11